
A novel cMET inhibitor, MK8033, potentiates the activity of carboplatin/paclitaxel in ovarian cancer cell lines
Marchion, D., Ramirez-Diaz, I., Bou Zgheib, N., Xiong, Y., Stickles, X., Judson Lancaster, P., Gonzalez Bosquet, J., Wenham, R., Apte, S., Lancaster, J.Volume:
130
Langue:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2013.04.375
Date:
July, 2013
Fichier:
PDF, 59 KB
english, 2013